Evaluation of the Efficacy and Safety of LW402 Tablets in Patients With Non-Segmental Vitiligo
Clinical trial NCT07556471 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07556471
- Sponsor
- Shanghai Longwood Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-31
- Primary completion
- 2028-02-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.